SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the September 2022 quarter is pegged at Rs. 1406.12 millions, about 10.31% up against Rs. 1274.68 millions recorded during the year-ago period.Profit for the quarter ended September 2022 grew by 2.98% to Rs. 237.12 millions from Rs. 230.26 millions.Operating profit surged to 345.93 millions from the corresponding previous quarter of 327.31 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1406.12 1274.68 10.31 2640.83 2496.57 5.78 4720.79 4229.08 11.63
Other Income 56.85 34.61 64.26 121.80 54.72 122.59 99.98 57.43 74.09
PBIDT 345.93 327.31 5.69 579.99 600.55 -3.42 1054.68 927.83 13.67
Interest 1.39 2.04 -31.86 5.50 5.79 -5.01 14.51 15.52 -6.51
PBDT 344.54 325.27 5.92 574.49 594.76 -3.41 1040.17 912.31 14.01
Depreciation 24.22 19.92 21.59 44.91 39.09 14.89 80.88 75.60 6.98
PBT 320.32 305.35 4.90 529.58 555.67 -4.70 959.29 836.71 14.65
TAX 83.20 75.09 10.80 142.34 148.38 -4.07 265.74 214.21 24.06
Deferred Tax 1.65 -2.46 -167.07 1.39 -0.90 -254.44 7.20 2.47 191.50
PAT 237.12 230.26 2.98 387.24 407.29 -4.92 693.55 622.50 11.41
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 24.60 25.68 -4.19 21.96 24.06 -8.70 22.34 21.94 1.83

Lincoln Pharma Share Price

682.10 40.85 (6.37%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×